Predict your next investment

HEALTHCARE | Drug Delivery
accubreakpharmaceuticals.com

See what CB Insights has to offer

Total Raised

$4.05M

Investors Count

2

Accu-Break Pharmaceuticals Funding, Accu-Break Pharmaceuticals Valuation & Accu-Break Pharmaceuticals Revenue

4 Fundings

Accu-Break Pharmaceuticals's latest funding round was a Unattributed - II for $0.5M on June 2, 2015.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

6/2/2015

Unattributed - II

$0.5M

Undisclosed Investors

$0.00B

((9.99x))

FY 1234

1

5/20/2013

Unattributed

$99M

$0.00B

((9.99x))

FY 1234

10

4/23/2007

Debt

$99M

$0.00B

((9.99x))

FY 1234

10

Other Investors

$99M

$0.00B

((9.99x))

FY 1234

10

Date

6/2/2015

5/20/2013

4/23/2007

Round

Unattributed - II

Unattributed

Debt

Other Investors

Amount

$0.5M

$99M

$99M

$99M

Investors

Undisclosed Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

10

10

Accu-Break Pharmaceuticals Investors

2 Investors

Accu-Break Pharmaceuticals has 2 investors. Pequot Capital Mangement invested in Accu-Break Pharmaceuticals's Other Investors funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1
Other Investors

Private Equity

Connecticut

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

First funding

00/00/0000

Last Funding

00/00/0000

Investor

Subscribe to see more

Rounds

1
Other Investors

Subscribe to see more

Board Seats

Subscribe to see more

Type

Private Equity

Location

Connecticut

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.